Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia

Clinical Chemistry

Volumn 43, Issue 5, 1997, Pages 808-815

  Planella, Teresa ^a   Cortés, Mariano ^a   Martínez Brú, Cecília ^a   González Sastre, Francesc ^a   Ordóñez Llanos, Jordi ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

apolipoproteins; discriminant analysis; Friedewald formula; HDL cholesterol; multiple regression; triglycerides; VLDL cholesterol

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACCURACY; ALGORITHM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DYSLIPIDEMIA; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0030900029     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.5.808     Document Type: Article

References (28)

1. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
2. Beaumont JL, Carlson LA, Cooper GR, Fejfar Z, Fredrickson DS, Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ 1970;43:891-908.
3. Manninen V, Tekanen L, Koskinen P, Huttunen JK, Mänttäri M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL-cholesterol and HDL-cholesterol on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 1992;85:37-45.
4. McNamara JR, Cole TG, Contois JF, Ferguson CA, Ordovas JM, Schaefer EJ. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem 1995;41:232-40.
5. Jialal I, Hirany SV, Devaraj S, Sherwood TA. Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation). Am J Clin Pathol 1995;104:76-81.
6. Manual of laboratory operations. Lipid Research Clinics program, lipid and lipoprotein analysis (revised 1982). Washington, DC: NIH, US Dept. of Health and Human Services.
7. Warnick GR. Laboratory measurement of lipid and lipoprotein risk factors. Scand J Clin Lab Invest 1990;90:9-19.
8. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Bachorick PS, Ross JW, for the National Cholesterol Education Program Working Group on Lipoprotein Measurements. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995;41:1414-20.
10. Sniderman AD, Cianflone K. Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias [Editorial]. Clin Chem 1996;42:489-91.
11. Bhatnagar D, Durrington PN. Does measurement of apolipoproteins add to the clinical diagnosis and management of dyslipidemias? Curr Opin Lipidol 1993;4:299-304.
12. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais G, Lupien PJ. Prevalence of dyslipemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study). Am J Cardiol 1995;75:1189-95.
13. Bachorick PS. Collection of blood samples for lipoprotein analysis. Clin Chem 1982;28:1357-8.
14. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Comparability of apolipoprotein B values by use of International Reference Material. Clin Chem 1994;40:586-92.
15. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedure for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 1983;21:709-20.
16. Bablok W, Passing H. Application of statistical procedures in analytical instruments testing. J Autom Chem 1985;7:74-9.
17. NCRP Report 58. A handbook of radioactivity measurement procedures. Washington, DC, 1978:290-1.
18. Stein Y. Comparison of European and USA guidelines for prevention of coronary heart disease. Atherosclerosis 1994;110(Suppl) S41-4.
19. Schectman G, Patsches M, Sasse EA. Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin Chem 1996;42:732-7.
20. Laker MF, Evans K. Analysis of apolipoproteins [Review]. Ann Clin Biochem 1996;33:5-22.
21. Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorick PS, Kwiterovitch P Jr. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med 1982;97:833-9.
22. Dammerman M, Breslow JL Genetic basis of lipoprotein disorders. Circulation 1995;91:505-12.
23. DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very-low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study. JAMA 1986;256:2372-7.
24. Rao A, Parker AH, El-Sheroni NA, Babelly MM. Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods. Clin Chem 1988;34:2352-4.
25. Warnick JR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on basis of nationally recommended cutpoints. Clin Chem 1990;36:15-9.
26. Wilson PW, Abbott RD, Garrison RJ, Castelli WP. Estimation of very-low-density lipoprotein cholesterol from data of triglyceride concentration in plasma. Clin Chem 1981;27:2008-10.
27. Sentí M, Pedro-Botet J, Nogués X, Rubíes-Prat J. Influence of intermediate-density lipoproteins on the accuracy of the Friede-wald formula. Clin Chem 1991;37:1394-7.
28. Vega GL, Grundy SM. Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy. JAMA 1990;264: 2759-63.